Prospective multicEntric NonranDomized Registry
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT02496169
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 400 participants
- Sponsor
- Eucatech AG
- Registry
-
NCT02496169
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02496169. Non-randomized; no masking; primary purpose treatment. Start 2015-07 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prospective multicEntric NonranDomized Registry
- Acronym
- ExPEND
- Condition
- Coronary Artery Disease
- Intervention (Device)
- eucaLimus
- Lead sponsor
- Eucatech AG
- Collaborator
- CERES GmbH
Record details
- Record id
cardio:ct-nct02496169- Content hash
8c13bbc0debd66d3d84f602bacaa1c19c3c727c1d1b1fc648e867d0b220cd06d